美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

INVESCO BIOTECHNOLOGY & GENOME ETF

95.18

+1.811.94%

成交量：5,452

成交額：51.85萬

市值：4.13億

市盈率：53.08

高：95.28

開：94.85

低：94.77

收：93.37

52周最高：98.82

52周最低：67.69

股本：434.00萬

流通股本：434.00萬

量比：1.15

換手率：0.13%

股息：1.55

股息率：1.63%

每股收益(TTM):1.79

每股收益(LYR):18.65

淨資產收益率：24.76%

總資產收益率：0.08%

市淨率：1.67

市盈率(LYR):5.10

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Sling Therapeutics 籌集 1.23 億美元，用於推進甲狀腺相關眼病藥物的研發

百時美施貴寶就安進擬推出的Opdivo生物類似藥提起訴訟

百時美施貴寶就奧普迪沃擬推出的生物類似藥起訴安進

美國食品藥品監督管理局（FDA）批准了Scholar Rock公司的一款治療肌肉無力症的藥物

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/PBE"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":95.18,"timestamp":1789661257125,"preClose":93.3693,"halted":0,"volume":5452,"delay":0,"changeRate":0.019392883956504025,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"交易中","change":1.8107,"latestTime":"09-17 12:12:13 EDT","open":94.85,"high":95.28,"low":94.765,"amount":518511.31508,"amplitude":0.005516,"askPrice":95.52,"askSize":900,"bidPrice":95.32,"bidSize":700,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":93.3693,"sharesOutstanding":3180000,"nav":93.02867,"aum":405605001.2,"dividendRate":0.016284,"bidAskSpread":0.001979,"preHourTrading":{"tag":"盘前","latestPrice":93.3693,"preClose":93.3693,"latestTime":"07:00 EDT","volume":1,"amount":93.3693,"timestamp":1789642840517,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":92.89213,"preClose":93.3693,"latestTime":"19:30 EDT","volume":12,"amount":1120.613,"timestamp":1789601405975,"change":-0.47717,"changeRate":-0.005111,"amplitude":0},"volumeRatio":1.149938,"impliedVol":0.1146,"impliedVolPercentile":0.0359},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":1.149938,"shares":4340000,"dividePrice":1.5499,"high":95.28,"amplitude":0.005516,"preClose":93.3693,"low":94.765,"week52Low":67.69,"pbRate":"1.67","psRate":"240.63","week52High":98.82,"institutionHeld":0.2552,"latestPrice":95.18,"committee":-0.125,"eps":1.793292,"divideRate":0.016284,"volume":5452,"delay":0,"ttmEps":1.793292,"open":94.85,"prevYearClose":82.15,"prevWeekClose":92.91,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":93.03,"twentyDayClose":98.2643,"sixtyDayClose":85.4379},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667074086","title":"Sling Therapeutics 籌集 1.23 億美元，用於推進甲狀腺相關眼病藥物的研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2667074086","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667074086?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 19:01","pubTimestamp":1789556485,"startTime":"0","endTime":"0","summary":"Sling Therapeutics 筹集 1.23 亿美元，用于推进甲状腺相关眼病药物的研发Kunal Das/Siddhi Mahatole路透9月16日-药物研发公司Sling Therapeutics周三表示，已筹集1.23亿美元，用于推进其用于治疗甲状腺眼病的实验性口服药物的后期临床试验。该疾病会导致眼周发炎和肿胀，进而可能引发眼球突出和视力丧失。作为此次融资协议的一部分，Sling还任命了Forbion的Regina Salvat和Sectoral Asset Management的Franois Beaubien加入其董事会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4T4580NN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRDN","BK4599","IE00B4R5TH58.HKD","LU2242646821.SGD","PJP","BK4566","LU1057294990.SGD","TBXU","LU1061106388.HKD","LU0122379950.USD","LU0058720904.USD","BK4588","LU0109394709.USD","LU0289739699.SGD","PBE","IE00BJT1NW94.SGD","BK4139","LU2112291526.USD","BBH","BK4585","IBB","IE00BFTCPJ56.SGD","BK4533","IE00B2B36J28.USD","BK4581","LU0320765992.SGD","IE0002141913.USD","LU1571399168.USD","LU1983299246.USD","BIB","SG9999001440.SGD","AMGN","LU2089984988.USD","LU0889565916.HKD","BK4534","LU2242652126.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","IBBQ","LU0868494617.USD","IE0009355771.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667267605","title":"百時美施貴寶就安進擬推出的Opdivo生物類似藥提起訴訟","url":"https://stock-news.laohu8.com/highlight/detail?id=2667267605","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667267605?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:15","pubTimestamp":1789524901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2322448957.HKD","LU0058720904.USD","LU0320765992.SGD","AMGN","LU0109394709.USD","LU1236620834.HKD","BMY","LU1670711123.USD","PPH","LU0868494617.USD","LU1023059063.AUD","LU2272731600.USD","BK4566","LU1983299246.USD","IHE","BK4139","BK4559","LU2125154778.USD","LU0061475181.USD","BK4585","LU0289739699.SGD","BK4533","IE00BSNM7G36.USD","LU2272731865.HKD","PBE","LU1883839398.USD","XPH","IE0009355771.USD","LU0225284248.USD","LU0225771236.USD","LU1989771016.USD","TBXU","BK4534","LU0114720955.EUR","IBB","LU1868837300.USD","FTXH","BBH","LU1236620750.USD","LU1992135399.USD","LU2473716301.USD","LU2468319806.SGD","BIB","BK4588","IE00B4R5TH58.HKD","LU1868836591.USD","LU1868836757.USD","IBBQ","LU1261432733.SGD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667629132","title":"百時美施貴寶就奧普迪沃擬推出的生物類似藥起訴安進","url":"https://stock-news.laohu8.com/highlight/detail?id=2667629132","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667629132?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 01:29","pubTimestamp":1789493363,"startTime":"0","endTime":"0","summary":"百时美施贵宝就奥普迪沃拟推出的生物类似药起诉安进Blake Brittain路透9月15日-百时美施贵宝公司和小野制药公司已在特拉华州联邦法院起诉安进公司，试图阻止安进公司在美国推出其畅销癌症免疫疗法药物“欧迪沃”的生物类似药。百时美施贵宝和小野制药的发言人尚未立即回应置评请求。共同开发“欧狄沃”的百时美施贵宝和小野制药指控，安进的生物类似药将侵犯该药物所涉及的七项美国专利，并请求法院在专利有效期内禁止该生物类似药的销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4T4571DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","LU2089984988.USD","LU0096364046.USD","BK4585","LU2125154935.USD","LU0321505439.SGD","LU0122379950.USD","PJP","LU1061106388.HKD","LU1093756168.USD","LU1868837136.USD","LU0267386448.USD","LU1868836591.USD","LU1093756325.SGD","IE0002141913.USD","LU1670711123.USD","LU0306807586.USD","LU1057294990.SGD","LU1718418525.SGD","LU2125154778.USD","BK4532","BMY","BK4599","SG9999001440.SGD","LU1868836757.USD","LU2242652126.USD","LU2596442595.SGD","LU1291159041.SGD","LU2242646821.SGD","LU1323610961.USD","LU0289739699.SGD","LU1074936037.SGD","LU1989771016.USD","LU1868836914.USD","PBE","IBB","LU1670711040.USD","LU1571399168.USD","LU0114720955.EUR","LU0306806265.USD","IHE","LU0225771236.USD","LU1868837300.USD","IE00B2B36J28.USD","LU1670710661.SGD","LU2360032135.SGD","LU1261432733.SGD","LU0985481810.HKD","LU1236620750.USD","LU1023059063.AUD","LU2133065610.SGD","LU1670710588.SGD","IBBQ","LU1983299246.USD","BK4534","LU0882574055.USD","LU2112291526.USD","LU0889565916.HKD","LU0058720904.USD","LU0321505868.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4139","BK4566","LU2468319806.SGD","LU0225284248.USD","LU0456855351.SGD","BK4533","LU1585245621.USD","BK4559","LU0237698245.USD","IE00BSNM7G36.USD","LU1430594728.SGD","04332","TBXU","BK4007","AMGN","IE00BFTCPJ56.SGD","LU1032466523.USD","BBH","LU1883839398.USD","BK4588","LU0061475181.USD","BIB","LU0109394709.USD","FTXH","IE00BFXG1179.USD","IE00B4R5TH58.HKD","LU1236620834.HKD","LU0868494617.USD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666257258","title":"美國食品藥品監督管理局（FDA）批准了Scholar Rock公司的一款治療肌肉無力症的藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2666257258","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666257258?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 05:25","pubTimestamp":1789161915,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）批准了Scholar Rock公司的一款治疗肌肉无力症的药物路透9月11日-美国食品和药物管理局（FDA）周五批准了Scholar Rock公司开发的SRRK.O疗法，用于治疗一种会导致肌肉无力的罕见遗传性疾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL4T4531I4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","IE00B19Z9P08.USD","BK4585","IE00B19Z9Z06.USD","IE00B894F039.SGD","BIIB","BK4533","BK4532","PBE","BK4588","LU0109394709.USD","LU0320765992.SGD","THNR","BK4139","BMED","LU0889565916.HKD","SRRK","IBRN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":38,"pageCount":1,"totalSize":152,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PBE\",params:#limit:6,delay:false,,,undefined,":[]}}